EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Aptamer-based multiplexed proteomic technology for biomarker discovery

Larry Gold, Deborah Ayers, Jennifer Bertino, Christopher Bock, Ashley Bock, Edward Brody, Jeff Carter, Virginia Cunningham, Andrew Dalby, Bruce Eaton, Tim Fitzwater, Dylan Flather und 28 weitere

Nature Precedings · 14.06.2010

DOI: 10.1038/npre.2010.4538.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Precedings, online erschienen am 14.06.2010. Verfasst von Larry Gold und 39 weiteren Autor:innen. Die Arbeit wurde bisher 59-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interrogation of the human proteome in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology. We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 [mu]L of serum or plasma). Our current assay allows us to measure ~800 proteins with very low limits of detection (1 pM average), 7 logs of overall dynamic range, and 5% average coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding DNA aptamer concentration signature, which is then quantified with a DNA microarray. In essence, our assay takes advantage of the dual nature of aptamers as both folded binding entities with defined shapes and unique sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to discover unique protein signatures characteristic of various disease states. More generally, we describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.

Zitieren

APA

Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E., Carter, J., Cunningham, V., Dalby, A., Eaton, B., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., …, & Mehan, M. (2010). Aptamer-based multiplexed proteomic technology for biomarker discovery. Nature Precedings. https://doi.org/10.1038/npre.2010.4538.1

Vancouver

Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody E, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. Nature Precedings. 2010. doi:10.1038/npre.2010.4538.1

BibTeX
@article{Gold2010,
  author = {Gold, Larry and Ayers, Deborah and Bertino, Jennifer and Bock, Christopher and Bock, Ashley and Brody, Edward and Carter, Jeff and Cunningham, Virginia and Dalby, Andrew and Eaton, Bruce and Fitzwater, Tim and Flather, Dylan and Forbes, Ashley and Foreman, Trudi and Fowler, Cate and Gawande, Bharat and Goss, Meredith and Gunn, Magda and Gupta, Shashi and Halladay, Dennis and Heil, Jim and Heilig, Joe and Hicke, Brian and Husar, Gregory and Janjic, Nebojsa and Jarvis, Thale and Jennings, Susan and Katilius, Evaldas and Keeney, Tracy and Kim, Nancy and Kaske, Terese and Koch, Tad and Kraemer, Stephan and Kroiss, Luke and Le, Ngan and Levine, Daniel and Lindsey, Wes and Lollo, Bridget and Mayfield, Wes and Mehan, Mike},
  title = {Aptamer-based multiplexed proteomic technology for biomarker discovery},
  journal = {Nature Precedings},
  year = {2010},
  doi = {10.1038/npre.2010.4538.1}
}
Kostenlos starten →